YU44793A - Spirostanil glikozidi za lecenje hiperholesterolemije - Google Patents
Spirostanil glikozidi za lecenje hiperholesterolemijeInfo
- Publication number
- YU44793A YU44793A YU44793A YU44793A YU44793A YU 44793 A YU44793 A YU 44793A YU 44793 A YU44793 A YU 44793A YU 44793 A YU44793 A YU 44793A YU 44793 A YU44793 A YU 44793A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- glycosides
- spirostanil
- hypercholesterolemia
- treatment
- methylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Ovaj pronalazak odnosi se na steroidne glikozide (spirostanil glikozide) koji imaju formulu u kojoj Q1, Q2, Q3, Q4 i Q5 predstavljaju metilen, hidroksi supstituisan metilen ili etar supsdtuisani metilen, i postupke njihovog korišćenja kod sisara, posebno kao hipoholesterolemičnog agensa i antiateroskleroznog agensa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90491492A | 1992-06-26 | 1992-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU44793A true YU44793A (sh) | 1996-10-09 |
Family
ID=25419965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU44793A YU44793A (sh) | 1992-06-26 | 1993-06-25 | Spirostanil glikozidi za lecenje hiperholesterolemije |
Country Status (19)
Country | Link |
---|---|
US (2) | US5629295A (sh) |
EP (4) | EP0796863A2 (sh) |
JP (2) | JPH07504921A (sh) |
KR (1) | KR950702203A (sh) |
CN (1) | CN1085561A (sh) |
AP (1) | AP489A (sh) |
AU (1) | AU4226593A (sh) |
BG (1) | BG99261A (sh) |
BR (1) | BR9306619A (sh) |
CA (1) | CA2139104A1 (sh) |
CZ (1) | CZ331094A3 (sh) |
HR (1) | HRP930994A2 (sh) |
IL (1) | IL106055A0 (sh) |
MX (1) | MX9303826A (sh) |
OA (1) | OA10121A (sh) |
RU (1) | RU94046294A (sh) |
SK (1) | SK158394A3 (sh) |
WO (1) | WO1994000480A1 (sh) |
YU (1) | YU44793A (sh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2578399B2 (ja) * | 1992-06-26 | 1997-02-05 | ファイザー インク. | ステロイド−β−O−セロビオシドヘプタアルカノエートの製造方法 |
CZ280195A3 (en) * | 1993-04-28 | 1996-02-14 | Pfizer | Crystalline spirostanyl glycoside, monohydrate thereof, pharmaceutical composition based thereon and process for preparing crystalline steroidal glycoside |
US5502038A (en) * | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
FI96243C (fi) * | 1993-10-26 | 1996-05-27 | Ilmari Paakkinen | Menetelmä ja laite rakeisten maamassojen ominaisuuksien mittaamiseksi |
CA2180148A1 (en) * | 1993-12-28 | 1995-07-06 | Michael Paul Deninno | Hypocholesterolemic agents |
AU7948494A (en) * | 1993-12-28 | 1995-07-17 | Pfizer Inc. | Steroidal glycosides |
FR2722690B1 (fr) * | 1994-07-21 | 1996-10-25 | Univ Montpellier Ii | Compositions de saponines et/ou de leurs formes aglycones et leurs applications comme medicaments |
KR970705574A (ko) * | 1994-08-30 | 1997-10-09 | 스피겔 알렌 제이 | 스피로스타닐 글리코시드 결정(spirostanyl glycosidal crystals) |
EP0782451A1 (en) * | 1994-09-20 | 1997-07-09 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
WO1996038466A1 (en) * | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Steroidal glycosides |
US5698527A (en) * | 1995-08-08 | 1997-12-16 | Merck & Co., Inc. | Steroidal glycosides as antihyperlipidemic agents |
US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
KR20070117001A (ko) * | 1998-03-26 | 2007-12-11 | 파이토팜 피엘씨 | 알츠하이머병을 치료하기 위한 스밀라게닌 및안주로게닌-d |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
JP3370610B2 (ja) * | 1998-08-21 | 2003-01-27 | 武田薬品工業株式会社 | 害虫防除剤 |
US20030060425A1 (en) * | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US6343258B1 (en) | 1999-08-13 | 2002-01-29 | ALEXIS Brian | Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
CA2389670A1 (en) * | 1999-11-01 | 2001-05-10 | Forbes Medi-Tech Inc. | Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
US6429190B1 (en) | 2000-12-15 | 2002-08-06 | Pacifichealth Laboratories, Inc. | Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK) |
WO2002047614A2 (en) | 2000-12-15 | 2002-06-20 | Pacific Health Laboratories, Inc. | Nutritional composition for improving the efficacy of a lipase inhibitor |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
US6703530B2 (en) * | 2002-02-28 | 2004-03-09 | General Electric Company | Chemical reactor system and process |
CN102727501A (zh) * | 2002-03-27 | 2012-10-17 | 菲特法姆股份有限公司 | 皂角苷配基及其衍生物的用途 |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
US7718792B2 (en) * | 2002-10-28 | 2010-05-18 | Phytopharm Plc | Stereospecific reduction of sapogen-3-ones |
MX2007005137A (es) | 2004-11-23 | 2007-06-22 | Warner Lambert Co | Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia. |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
JP5564490B2 (ja) * | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗炎症性ファルマコアを含む化合物および使用法 |
EP2309860B1 (en) * | 2008-07-22 | 2014-01-08 | Trustees of Dartmouth College | Monocyclic cyanoenones and methods of use thereof |
JP2013528172A (ja) | 2010-05-21 | 2013-07-08 | ファイザー・インク | 2−フェニルベンゾイルアミド |
CA2828343A1 (en) | 2011-03-04 | 2012-09-13 | The Scripps Research Institute | Edn3-like peptides and uses thereof |
CU20110244A7 (es) * | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
AU2014255381A1 (en) | 2013-04-17 | 2015-10-08 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
AU2020209215B2 (en) | 2019-01-18 | 2023-02-02 | Astrazeneca Ab | PCSK9 inhibitors and methods of use thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3178418A (en) | 1963-02-26 | 1965-04-13 | Glaxo Lab Ltd | Monobromination at the 11-position of hecogenin and 3-lower alkanoyl esters thereof |
DE2926463A1 (de) * | 1978-07-05 | 1980-01-24 | Roecar Holdings Nv | Spiroketaline und ihre verwendung |
US4260603A (en) | 1979-01-02 | 1981-04-07 | Pegel Karl H | Sterol glycoside with activity as prostaglandin synthetase inhibitor |
NZ193564A (en) * | 1979-05-02 | 1985-01-31 | Aruba Pty Ltd | Steroid alkaloids from solanum sodomeum and pharmaceutical compositions |
US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
ES524614A0 (es) * | 1982-08-12 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos amino-14 esteroides. |
ES8404694A1 (es) * | 1982-08-20 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos derivos de amino-14 esteroides |
IT1188184B (it) | 1985-08-14 | 1988-01-07 | Texcontor Ets | Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante |
US5017562A (en) * | 1987-02-11 | 1991-05-21 | Regents Of The University Of Minnesota | Crystalline saponin-containing complex |
FR2621316B1 (fr) * | 1987-10-02 | 1991-06-21 | Nativelle Sa Ets | Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant |
US5010185A (en) * | 1989-06-13 | 1991-04-23 | Pfizer Inc. | Processes for tigogenin beta-cellobioside |
EP0524595A1 (en) * | 1991-07-23 | 1993-01-27 | Schering Corporation | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
AU2675092A (en) * | 1991-09-27 | 1993-04-27 | Procter & Gamble Pharmaceuticals, Inc. | Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure |
WO1993007167A1 (en) * | 1991-10-04 | 1993-04-15 | The Procter & Gamble Company | Cholesterol lowering compounds and process for making them |
EP0619822A1 (en) * | 1991-11-25 | 1994-10-19 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
US5530107A (en) * | 1992-10-15 | 1996-06-25 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
LT3595B (en) * | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
-
1993
- 1993-05-06 JP JP6502331A patent/JPH07504921A/ja active Pending
- 1993-05-06 EP EP97200455A patent/EP0796863A2/en not_active Withdrawn
- 1993-05-06 US US08/351,470 patent/US5629295A/en not_active Expired - Fee Related
- 1993-05-06 AU AU42265/93A patent/AU4226593A/en not_active Abandoned
- 1993-05-06 BR BR9306619A patent/BR9306619A/pt not_active Application Discontinuation
- 1993-05-06 EP EP97200454A patent/EP0796862A2/en not_active Withdrawn
- 1993-05-06 SK SK1583-94A patent/SK158394A3/sk unknown
- 1993-05-06 RU RU94046294/04A patent/RU94046294A/ru unknown
- 1993-05-06 EP EP93910951A patent/EP0647234A1/en not_active Withdrawn
- 1993-05-06 CZ CZ943310A patent/CZ331094A3/cs unknown
- 1993-05-06 WO PCT/US1993/004092 patent/WO1994000480A1/en not_active Application Discontinuation
- 1993-05-06 CA CA002139104A patent/CA2139104A1/en not_active Abandoned
- 1993-05-06 EP EP97200456A patent/EP0796864A2/en not_active Withdrawn
- 1993-06-17 AP APAP/P/1993/000539A patent/AP489A/en active
- 1993-06-17 IL IL106055A patent/IL106055A0/xx unknown
- 1993-06-24 HR HR07/904,914A patent/HRP930994A2/xx not_active Application Discontinuation
- 1993-06-25 YU YU44793A patent/YU44793A/sh unknown
- 1993-06-25 MX MX9303826A patent/MX9303826A/es unknown
- 1993-06-25 CN CN93107620A patent/CN1085561A/zh active Pending
-
1994
- 1994-12-13 BG BG99261A patent/BG99261A/xx unknown
- 1994-12-23 OA OA60598A patent/OA10121A/en unknown
- 1994-12-24 KR KR1019940704728A patent/KR950702203A/ko not_active Application Discontinuation
-
1995
- 1995-06-06 US US08/470,554 patent/US5703052A/en not_active Expired - Fee Related
-
1997
- 1997-02-14 JP JP9030588A patent/JPH09309897A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
OA10121A (en) | 1996-12-18 |
HRP930994A2 (en) | 1996-08-31 |
US5629295A (en) | 1997-05-13 |
CZ331094A3 (en) | 1995-09-13 |
US5703052A (en) | 1997-12-30 |
RU94046294A (ru) | 1996-10-10 |
BR9306619A (pt) | 1998-12-08 |
CN1085561A (zh) | 1994-04-20 |
EP0647234A1 (en) | 1995-04-12 |
IL106055A0 (en) | 1993-10-20 |
JPH09309897A (ja) | 1997-12-02 |
EP0796862A2 (en) | 1997-09-24 |
JPH07504921A (ja) | 1995-06-01 |
EP0796863A2 (en) | 1997-09-24 |
AP9300539A0 (en) | 1993-07-31 |
KR950702203A (ko) | 1995-06-19 |
WO1994000480A1 (en) | 1994-01-06 |
BG99261A (en) | 1995-06-30 |
AP489A (en) | 1996-05-02 |
EP0796864A2 (en) | 1997-09-24 |
MX9303826A (es) | 1994-02-28 |
AU4226593A (en) | 1994-01-24 |
SK158394A3 (en) | 1995-05-10 |
CA2139104A1 (en) | 1994-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU44793A (sh) | Spirostanil glikozidi za lecenje hiperholesterolemije | |
CO4520281A1 (es) | Antifungicos de tetrahidrofurano | |
DE69032434T2 (de) | Synergistische mikrobizide Kombinationen | |
NO942170L (sh) | ||
BR9809819A (pt) | Compostos e métodos para a inibição da expressão de vcam-1 | |
ATE206035T1 (de) | Haferextrakte enthaltende sonnenschutzmittel | |
DE68925801T2 (de) | Biozide Zusammensetzungen | |
DE3484997D1 (de) | Zellstimulierendes mittel. | |
ATE193647T1 (de) | Di- und trivalente kleine moleküle als selektininhibitoren | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
ATE177426T1 (de) | Pyrridino-, pyrrolidino- und azepino- substituierte oxime als antiatherosklerosemittel und antihypercholesterolemiemittel | |
MX9304793A (es) | Glicanas de actividad inmunoestimulante. | |
AR005642A1 (es) | Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios | |
AR247984A1 (es) | Metodo para la preparacion de una composicion sinergica que tiene actividad antiplaca o antigingivitis | |
ATE243205T1 (de) | C7-taxan-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
MX9306598A (es) | Composicion detergente que comprende un sistema supresor de espumas. | |
ATE152913T1 (de) | Biozide zusammensetzung die senfsamenextrakt enthält | |
DE69613395D1 (de) | Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel | |
DE69407057T2 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung | |
YU31191A (sh) | Novi derivati beta-fenilizoserina njegovo dobijanje i primena | |
HUP9901673A2 (hu) | A politrauma utáni többszörös szervelégtelenség megakadályozására, valamint az extracorporeális vérkeringés utáni akut szerv károsodás megakadályozására szolgáló anti-szelektin antitestek | |
FI944563A0 (fi) | Mikro-organismeja, valmistusmenetelmä ja käyttö | |
NO962221L (no) | Anvendelse av dimeticon for behandling av konstipasjon | |
AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
ES2081629T3 (es) | Composiciones odoriferas. |